CORC

在结果中检索

CORC

浏览/检索结果: 共61条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack Secondary Analysis of a Randomized Clinical Trial 会议论文
11th World Stroke Congress, OCT 20, 2018
作者:  Pan, Yuesong;  Chen, Weiqi;  Wang, Yilong;  Li, Hao;  Johnston, S. Claiborne
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/31
Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coronary Heart Disease 会议论文
作者:  Han, Yaling;  Wang, Zhiyong;  Pei, Hanjun;  Zhang, Li;  Yang, Yuejin
收藏  |  浏览/下载：9/0  |  提交时间：2019/11/19
Primary endpoint Outcomes of A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent (R) System) compared to TIVOLI in the Treatment of Patients with Coron 会议论文
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018-10-16
作者:  Han, Yaling;  Wang, Zhiyong;  Pei, Hanjun;  Zhang, Li;  Yang, Yuejin
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Comparison of efficacy and safety of first-line palliative chemotherapy with TX and XELOX regimens in patients with metastatic gastric adenocarcinoma: A randomized phase II trial. 会议论文
作者:  Zhu, Xiaodong;  Li, Jin;  Zhao Xiaoying;  Guo, Weijian;  Liu, Xin
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutation. 会议论文
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer 会议论文
作者:  Fizazi, Karim;  Tran, Namphuong;  Fein, Luis Enrique;  Matsubara, Nobuaki;  Antolin, Alfredo Rodriguez
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare). 会议论文
作者:  Zhu, Ji;  Sun, Xinchen;  Zhang, Tao;  Liu, Anwen;  Zhu, Yuan
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
LATITUDE: A phase III, double-blind, randomized trial of androgen deprivation therapy with abiraterone acetate plus prednisone or placebos in newly diagnosed high-risk metastatic hormone-naive prostate cancer. 会议论文
作者:  Fizazi, Karim;  Namphuong Tran;  Enrique Fein, Luis;  Matsubara, Nobuaki;  Rodriguez Antolin, Alfredo
收藏  |  浏览/下载：17/0  |  提交时间：2019/12/05
A randomized, double-blind, placebo-controlled, multi-centered phase 3 trial comparing fruquintinib versus placebo plus best supportive care in Chinese patients with metastatic colorectal cancer (FRESCO). 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Li, Jin;  Qin, Shukui;  Bai, Yuxian;  Deng, Yanhong;  Yang, Lei
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/04
A multicenter, randomized, open-label, phase II trial of erlotinib versus etoposide plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating m 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2017-05-20
作者:  Xing, Ligang;  Wu, Gang;  Wang, Lvhua;  Li, Jian-Cheng;  Wang, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04

©版权所有 ©2017 CSpace - Powered by CSpace